Zhejiang Tailin BioEngineering Co.,Ltd
Shenzhen Stock ExchangeTotal Valuation
Zhejiang Tailin BioEngineering Co.,Ltd carries a market capitalization of 2.60B, placing it among publicly traded companies globally. Its enterprise value stands at 3.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.60B |
| Enterprise Value | 3.28B |
Share Statistics
Zhejiang Tailin BioEngineering Co.,Ltd currently has 121.20M shares outstanding.
| Shares Outstanding | 121.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Zhejiang Tailin BioEngineering Co.,Ltd trades at a trailing price-to-earnings ratio of 210.96. The price-to-sales ratio is 12.73, and the price-to-book ratio stands at 9.59.
| PE Ratio | 210.96 |
| PS Ratio | 12.73 |
| PB Ratio | 9.59 |
| P/TBV Ratio | 4.50 |
| P/FCF Ratio | 65.45 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Zhejiang Tailin BioEngineering Co.,Ltd trades at an EV/EBITDA multiple of 202.30 and an EV/FCF ratio of 61.17. The EV/Sales ratio of 11.90 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 202.30 provides insight into valuation relative to core operating earnings.
| EV / Sales | 11.90 |
| EV / EBITDA | 202.30 |
| EV / EBIT | 202.30 |
| EV / FCF | 61.17 |
Financial Position
Zhejiang Tailin BioEngineering Co.,Ltd maintains a current ratio of 4.00, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.00 |
| Quick Ratio | 1.66 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 4.49 |
| Return on Assets (ROA) | 1.76 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 4.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.13 |
Taxes
Over the trailing twelve months, Zhejiang Tailin BioEngineering Co.,Ltd has paid -93,382.07 in income taxes, reflecting an effective tax rate of 8.37.
| Income Tax | -93,382.07 |
| Effective Tax Rate | 8.37 |
Stock Price Statistics
Zhejiang Tailin BioEngineering Co.,Ltd's stock has gained approximately 1.08542% over the past 52 weeks. The 50-day moving average sits at 22.36, while the 200-day moving average is 26.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.08542% |
| 50-Day Moving Average | 22.36 |
| 200-Day Moving Average | 26.45 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Zhejiang Tailin BioEngineering Co.,Ltd generated 275.30M in revenue and converted that into 16.62M in net income, yielding earnings per share of 0.14. EBITDA reached 16.20M, while operating income came in at 16.20M.
| Revenue | 275.30M |
| Gross Profit | 120.15M |
| Operating Income | 16.20M |
| Pretax Income | 16.52M |
| Net Income | 16.62M |
| EBITDA | 16.20M |
| EBIT | 16.20M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
Total book value stands at 365.36M, with working capital of 414.14M providing operational flexibility.
| Cash & Cash Equivalents | 228.95M |
| Total Debt | N/A |
| Net Debt | -148.85M |
| Equity (Book Value) | 365.36M |
| Book Value Per Share | 3.02 |
| Working Capital | 414.14M |
Cash Flow
After subtracting -53.56M in capital expenditures, free cash flow totaled -53.56M - equivalent to -0.44 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -53.56M |
| Free Cash Flow | -53.56M |
| FCF Per Share | -0.44 |
Margins
Zhejiang Tailin BioEngineering Co.,Ltd operates with a gross margin of 43.64, reflecting its pricing power and cost economics. The operating margin of 5.88 and net profit margin of 6.04 provide insight into operational efficiency.
| Gross Margin | 43.64 |
| Operating Margin | 5.88 |
| Pretax Margin | 6.00 |
| Profit Margin | 6.04 |
| EBITDA Margin | 5.88 |
Dividends & Yields
The company's payout ratio of 0.16 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | 0.16 |
| Shareholder Yield | 0.04 |
| FCF Yield | 1.53 |
Stock Splits
Zhejiang Tailin BioEngineering Co.,Ltd's most recent stock split took place on May 11, 2023 with a 10:13 split ratio.
| Last Split Date | 5/11/2023 |
| Split Ratio | 10:13 |
Scores
Zhejiang Tailin BioEngineering Co.,Ltd posts an Altman Z-Score of 16.24, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.24 |